Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)

NCT00824746 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Gefitinib retreatment

Sponsor

Chonnam National University Hospital

Collaborators

[object Object]